Get Involved: ISPE Virology Special Interest Group
The current COVID-19 pandemic has heightened the awareness and attention to virus safety and risk mitigation for manufacturers. Each manufacturer has a strategy in place to mitigate the risk, however by manufacturers working together, this can lead to synergies and best practices in the way that the risk is managed. Also, additional guidance is required by the Industry in a field that is constantly evolving and introducing more ways of manufacturing biopharmaceuticals including continuous manufacturing, single-use manufacturing equipment in line with Regulatory Guidance updates and appropriate virus safety measures need to be in place.